Cargando…
Targeting the Angiotensin II Type 1 Receptor in Cerebrovascular Diseases: Biased Signaling Raises New Hopes
The physiological and pathophysiological relevance of the angiotensin II type 1 (AT(1)) G protein-coupled receptor no longer needs to be proven in the cardiovascular system. The renin–angiotensin system and the AT(1) receptor are the targets of several classes of therapeutics (such as angiotensin co...
Autores principales: | Delaitre, Céline, Boisbrun, Michel, Lecat, Sandra, Dupuis, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269339/ https://www.ncbi.nlm.nih.gov/pubmed/34201646 http://dx.doi.org/10.3390/ijms22136738 |
Ejemplares similares
-
The AT(1)/AT(2) Receptor Equilibrium Is a Cornerstone of the Regulation of the Renin Angiotensin System beyond the Cardiovascular System
por: Colin, Mélissa, et al.
Publicado: (2023) -
Roxadustat for SARS-CoV-2 Infection: Old Signaling Raised New Hopes
por: Alkazmi, Luay, et al.
Publicado: (2022) -
Biased Signaling of the Angiotensin II Type 1 Receptor Can Be Mediated through Distinct Mechanisms
por: Bonde, Marie Mi, et al.
Publicado: (2010) -
β-Arrestin–Biased Angiotensin II Receptor Agonists for COVID-19
por: Manglik, Aashish, et al.
Publicado: (2020) -
Raising more than just hope for cancer treatment
por: Williams, Ruth
Publicado: (2006)